Ledger.Open graph →
SEC Form D · filed September 7, 2021

Asher Biotherapeutics, Inc

Offering
$108.0M
Sold
$108.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Yik Andy Yeung · South San Francisco, CAExecIvana Djuretic · South San Francisco, CAExec · DirectorKyle Elrod · South San Francisco, CAExecReid Huber · Boston, MADirectorCraig Gibbs · South San Francisco, CAExec · DirectorJeffrey Tong · Boston, MADirectorYik Andy Yeung · South San Francisco, CAExecIvana Djuretic · South San Francisco, CAExec · DirectorKyle Elrod · South San Francisco, CAExecReid Huber · Boston, MADirectorCraig Gibbs · South San Francisco, CAExec · DirectorJeffrey Tong · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗